Tamoxifen for hepatocellular carcinoma

Published: May 26, 2021
Abstract
Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of tamoxifen in people with hepatocellular carcinoma, irrespective of sex, administered dose, type of formulation, and duration of...
Paper Details
Title
Tamoxifen for hepatocellular carcinoma
Published Date
May 26, 2021
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.